{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,16]],"date-time":"2026-06-16T14:36:51Z","timestamp":1781620611116,"version":"3.54.5"},"reference-count":48,"publisher":"Stanford University Press","license":[{"start":{"date-parts":[[2025,8,1]],"date-time":"2025-08-01T00:00:00Z","timestamp":1754006400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,8,1]],"date-time":"2025-08-01T00:00:00Z","timestamp":1754006400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,4,22]],"date-time":"2025-04-22T00:00:00Z","timestamp":1745280000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Mass Spectrometry and Advances in the Clinical Lab"],"published-print":{"date-parts":[[2025,8]]},"DOI":"10.1016\/j.jmsacl.2025.04.008","type":"journal-article","created":{"date-parts":[[2025,4,23]],"date-time":"2025-04-23T13:12:05Z","timestamp":1745413925000},"page":"16-27","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":4,"special_numbering":"C","title":["Definitive urine drug testing in emergency medicine: Recreational and psychiatric drug findings"],"prefix":"10.21627","volume":"37","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-3709-4162","authenticated-orcid":false,"given":"Thomas G.","family":"Rosano","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"S.M.Touhidul","family":"Islam","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"John M.","family":"Rumberger","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"suffix":"Jr.","given":"Robert M.","family":"Konetchy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michelle","family":"Wood","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joseph A.","family":"Sorce","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Karl A.","family":"Robstad","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Heather","family":"Long","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"4811","reference":[{"key":"10.1016\/j.jmsacl.2025.04.008_b0005","doi-asserted-by":"crossref","unstructured":"K. Urbanoski, J. Cheng, J. Rehm, P. Kurdyak. Frequent use of emergency departments for mental and substance use disorders. Emerg. Med. J., 35 (4) (2018) 220-225, https:\/\/doi.org\/ 10.1136\/emermed-2015-205554.","DOI":"10.1136\/emermed-2015-205554"},{"key":"10.1016\/j.jmsacl.2025.04.008_b0010","doi-asserted-by":"crossref","unstructured":"L.W. Suen, A.N. Makam, H.R. Snyder, D. Repplinger, M.B. Kushel, M. Martin, O.K. Nguyen, National prevalence of alcohol and other substance use disorders among emergency department visits and hospitalizations: NHAMCS 2014-2018. J. Gen. Intern. Med., 37 (10) (2022), 2420-2428, https:\/\/ doi.org\/10.1007\/s11606-021-07069-w.","DOI":"10.1007\/s11606-021-07069-w"},{"key":"10.1016\/j.jmsacl.2025.04.008_b0015","doi-asserted-by":"crossref","unstructured":"M.R. Lavergne, M. Shirmaleki, J.P. Loyal, W. Jones, T.L. Nicholls, C.G. Sch\u00fctz, A. Vaughan, H. Samji, J.H. Puyat, R. Kaoser, M. Kaulius, W. Small, Emergency department use for mental and substance use disorders: descriptive analysis of population-based, linked administrative data in British Columbia, Canada. B.M.J., 12 (1) (2022), e057072, https:\/\/doi.org\/10.1136\/bmjopen-2021-057072.","DOI":"10.1136\/bmjopen-2021-057072"},{"key":"10.1016\/j.jmsacl.2025.04.008_b0020","unstructured":"Substance Abuse and Mental Health Services Administration. (2023). Drug Abuse Warning Network (DAWN): National estimates from drug-related emergency department visits. 2023. Publication Number PEP24-07-033. Rockville, MD: Center for Behavioral Health Statistics and Quality, Substance Abuse and Mental Health Services Administration. Retrieved on 01\/07\/25 from https:\/\/www.samhsa.gov\/data\/sites\/default\/files\/reports\/rpt53161\/dawn-national-estimates-2023.pdf."},{"key":"10.1016\/j.jmsacl.2025.04.008_b0025","doi-asserted-by":"crossref","unstructured":"M.O. Lee, P.M. Vivier, D.B. Diercks. Is the self-report of recent cocaine or methamphetamine use reliable in illicit stimulant drug users who present to the Emergency Department with chest pain? J. Emerg. Med., 37 (2) (2009), 237-241, doi.org\/10.1016.","DOI":"10.1016\/j.jemermed.2008.05.024"},{"key":"10.1016\/j.jmsacl.2025.04.008_b0030","doi-asserted-by":"crossref","unstructured":"I. Virmani, A. Oteo, M. Dunn, D. Vidler, C. Roper, J. Officer, G. Hardy, P.I. Dargan, M. Eddleston, J.G. Cooper, S.L. Hill, R. Macfarlane, L. Keating, M. Haden, S. Hudson, S.H.L. Thomas, Accuracy of substance exposure history in patients attending emergency departments after substance misuse; a comparison with biological sample analysis, Clin. Toxicol., 61 (1) (2023), 39-46, https:\/\/ doi: 10.1080\/15563650.2022.2131566.","DOI":"10.1080\/15563650.2022.2131566"},{"issue":"11","key":"10.1016\/j.jmsacl.2025.04.008_b0035","doi-asserted-by":"crossref","first-page":"693","DOI":"10.1080\/15563650.2024.2402070","article-title":"Reported recreational drug and new psychoactive substance use versus laboratory detection of substances by high-resolution mass spectrometry in patients presenting to an emergency department in London with acute drug toxicity","volume":"62","author":"Wolfe","year":"2024","journal-title":"Clin. Toxicol.,"},{"key":"10.1016\/j.jmsacl.2025.04.008_b0040","doi-asserted-by":"crossref","unstructured":"H.C. Mofenson, J. Greensher. \u201cThe nontoxic ingestion\u201d. Pediatric Clinics of North America, 7 (3) (1970), 583-90, https:\/\/doi.org\/1016\/s0031-3955(16)32453-1.","DOI":"10.1016\/S0031-3955(16)32453-1"},{"issue":"3","key":"10.1016\/j.jmsacl.2025.04.008_b0045","first-page":"273","article-title":"An evaluation of the diagnostic accuracy of liquid chromatography-tandem mass spectrometry versus immunoassay drug testing in pain patients","volume":"13","author":"Pesce","year":"2010","journal-title":"Pain Physician"},{"issue":"3","key":"10.1016\/j.jmsacl.2025.04.008_b0050","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1093\/jat\/bkac089","article-title":"False-positive amphetamines in urine drug screens: A 6-year review","volume":"47","author":"Pope","year":"2023","journal-title":"J. Anal. Toxicol.,"},{"key":"10.1016\/j.jmsacl.2025.04.008_b0055","doi-asserted-by":"crossref","unstructured":"A. Saitman, H.D. Park, R.L. Fitzgerald. False-positives interferences of common urine drug screen immunoassays: a review. J. Anal. Toxicol., 38 (7) (2014), 387-396, https:\/\/doi.org\/ 10.1093\/jat\/bku075. Epub 2014 Jul 1.","DOI":"10.1093\/jat\/bku075"},{"key":"10.1016\/j.jmsacl.2025.04.008_b0060","doi-asserted-by":"crossref","first-page":"130","DOI":"10.1002\/dta.1371","article-title":"False-positive phencyclidine immunoassay results caused by 3,4-methylenedioxypyrovalerone (MDPV)","volume":"5","author":"Macher","year":"2020","journal-title":"Drug Test. Anal.,"},{"issue":"4","key":"10.1016\/j.jmsacl.2025.04.008_b0065","first-page":"359","article-title":"KIMS, CEDIA, and HS-CEDIA immunoassays are inadequately sensitive for detection of benzodiazepines in urine from patients treated for chronic pain","volume":"17","author":"Darragh","year":"2014","journal-title":"Pain Physician"},{"issue":"15\u201316","key":"10.1016\/j.jmsacl.2025.04.008_b0070","doi-asserted-by":"crossref","first-page":"1199","DOI":"10.1016\/j.cca.2012.03.017","article-title":"Therapeutic monitoring of benzodiazepines in the management of pain: current limitations of point of care immunoassays suggesting testing by mass spectrometry to assure accuracy and improve patient safety","volume":"413","author":"Mikel","year":"2012","journal-title":"Clin. Chim. Acta"},{"issue":"1","key":"10.1016\/j.jmsacl.2025.04.008_b0075","doi-asserted-by":"crossref","first-page":"71","DOI":"10.36076\/ppj.2010\/13\/71","article-title":"Comparison of clonazepam compliance by measurement of urinary concentrations by immunoassay and LC-MS\/MS in pain management population","volume":"13","author":"West","year":"2010","journal-title":"Pain Physician"},{"key":"10.1016\/j.jmsacl.2025.04.008_b0080","doi-asserted-by":"crossref","first-page":"175","DOI":"10.36076\/ppj.2011\/14\/175","article-title":"Comparative evaluation of the accuracy of immunoassay with liquid chromatography tandem mass spectrometry (LC\/MS\/MS) of urine drug testing (UDT) opioids and illicit drugs in chronic pain patients","volume":"14","author":"Manchikanti","year":"2011","journal-title":"Pain Physician"},{"issue":"6","key":"10.1016\/j.jmsacl.2025.04.008_b0085","first-page":"E583","article-title":"Clinical benefits of direct-to-definitive testing for monitoring compliance in pain management","volume":"21","author":"Gencheva","year":"2018","journal-title":"Pain Physician"},{"issue":"4","key":"10.1016\/j.jmsacl.2025.04.008_b0090","doi-asserted-by":"crossref","first-page":"821","DOI":"10.1093\/pm\/pnab303","article-title":"Application and clinical value of definitive drug monitoring in pain management and addiction medicine","volume":"23","author":"Rosano","year":"2022","journal-title":"Pain Med.,"},{"key":"10.1016\/j.jmsacl.2025.04.008_b0095","doi-asserted-by":"crossref","DOI":"10.1016\/j.drugalcdep.2021.109195","article-title":"Emergency Department Drug Surveillance (EDDS) hospital's urinalysis results compared with expanded re-testing by an independent laboratory, a pilot study","volume":"230","author":"Schwartz","year":"2022","journal-title":"Drug Alcohol Depend.,"},{"issue":"8","key":"10.1016\/j.jmsacl.2025.04.008_b0100","doi-asserted-by":"crossref","first-page":"628","DOI":"10.1093\/jat\/bkw050","article-title":"Definitive drug and metabolite screening in urine by UPLC-MS-MS using a novel calibration technique","volume":"40","author":"Rosano","year":"2016","journal-title":"J. Anal. Toxicol.,"},{"issue":"1","key":"10.1016\/j.jmsacl.2025.04.008_b0105","doi-asserted-by":"crossref","first-page":"e644","DOI":"10.1002\/cpz1.644","article-title":"Novel matrix normalization technique for accurate LC-ESI-MS\/MS detection and quantification of drugs and their metabolites in toxicology research and practice","volume":"3","author":"Rosano","year":"2023","journal-title":"Current Protocols"},{"issue":"5","key":"10.1016\/j.jmsacl.2025.04.008_b0110","doi-asserted-by":"crossref","first-page":"353","DOI":"10.1093\/jat\/bky106","article-title":"Application of high-resolution UPLC-MSe\/TOF confirmation in forensic urine drug screening by UPLC-MS\/MS","volume":"43","author":"Rosano","year":"2019","journal-title":"J. Anal. Toxicol.,"},{"issue":"6","key":"10.1016\/j.jmsacl.2025.04.008_b0115","doi-asserted-by":"crossref","first-page":"536","DOI":"10.1093\/jat\/bkx035","article-title":"Screening and Quantification of 64 Drugs and Metabolites in Human Urine using UPLC-MS-MS Analysis with Threshold Accurate Calibration","volume":"41","author":"Rosano","year":"2017","journal-title":"J. Anal. Toxicol.,"},{"issue":"8","key":"10.1016\/j.jmsacl.2025.04.008_b0120","doi-asserted-by":"crossref","first-page":"901","DOI":"10.1093\/jat\/bkab052","article-title":"Matrix normalization techniques for definitive urine drug testing","volume":"45","author":"Rosano","year":"2021","journal-title":"J. Anal. Toxicol.,"},{"key":"10.1016\/j.jmsacl.2025.04.008_b0125","doi-asserted-by":"crossref","unstructured":"T.G. Rosano, J. Cooper, K.L. Scholz, M. Wood. Expanded confirmation of cannabinoids in forensic toxicology casework by isomer-selective UPLC-MS\/MS analysis. J. Anal. Toxicol. 47 (8) (2023), 709\u2013718, https\/doi.org\/10.1093\/jat\/bkad048.","DOI":"10.1093\/jat\/bkad048"},{"key":"10.1016\/j.jmsacl.2025.04.008_b0130","unstructured":"R. Lee, A. Traynor, J. LeCount, M. Wood. Quantitative analysis of barbiturates in urine using UPLC-MS\/MS. Waters Application Note 720004466, September 2014. https:\/\/www.waters.com\/nextgen\/en\/library\/application-notes\/2014\/quantitive-analysis-of-barbiturates-in-urine-using-uplc-ms-ms.html?srsltid=AfmBOore9v4d75wK-4rqU-reQw3HY-Ov9ufK9AoNuYErxEw7I8j2MNKB (accessed 23 December 2024)."},{"key":"10.1016\/j.jmsacl.2025.04.008_b0135","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1016\/j.clinms.2020.10.003","article-title":"Analysis of 17 fentanyls in plasma and blood by UPLC-MS\/MS with interpretation of findings in surgical and postmortem casework","volume":"18","author":"Danaceau","year":"2020","journal-title":"Clin. Mass Spectrom.,"},{"key":"10.1016\/j.jmsacl.2025.04.008_b0140","unstructured":"R. Lowry. VassarStats: Website for statistical computation. http:\/\/vassarstats.net\/ (accessed 28 November 2024)."},{"key":"10.1016\/j.jmsacl.2025.04.008_b0145","doi-asserted-by":"crossref","unstructured":"E. West, P. Cameron, G. O'Reilly, O.H. Drummer, A. Bystrzycki. Accuracy of current clinical diagnosis in recreational drug-related attendance to the emergency department. Emerg. Med. Australas. 20 (4) (2008), 333-8. https:\/\/doi: 10.1111\/j.1742-6723.2008.01110.x.","DOI":"10.1111\/j.1742-6723.2008.01110.x"},{"key":"10.1016\/j.jmsacl.2025.04.008_b0150","doi-asserted-by":"crossref","unstructured":"D. McCutcheon, J. Soderstrom, M. Raghavan, F. Oosthuizen, B. Douglas, S. Burrows, J.L. Smith, D. Fatovich. Illicit drugs in the emergency department: Can we determine on clinical grounds if patients are intoxicated? Results from the Western Australian Illicit Substance Evaluation (WISE) study. Drug Alcohol Rev., 42 (7) (2023) 1807-1815. https:\/\/doi: 10.1111\/dar.13738. Epub 2023 Aug 16.","DOI":"10.1111\/dar.13738"},{"issue":"2","key":"10.1016\/j.jmsacl.2025.04.008_b0155","doi-asserted-by":"crossref","first-page":"180","DOI":"10.1007\/s13181-022-00924-0","article-title":"Characterization of nonfatal opioid, cocaine, methamphetamine, and polydrug exposure and clinical presentations reported to the toxicology investigators consortium core registry, January 2010-December","volume":"19","author":"Glidden","year":"2023","journal-title":"J. Med. Toxicol.,"},{"key":"10.1016\/j.jmsacl.2025.04.008_b0160","doi-asserted-by":"crossref","first-page":"90","DOI":"10.1016\/j.ajem.2022.08.030","article-title":"High risk and low prevalence diseases: serotonin syndrome","volume":"61","author":"Spadaro","year":"2022","journal-title":"Am. J. Emerg. Med.,"},{"key":"10.1016\/j.jmsacl.2025.04.008_b0165","doi-asserted-by":"crossref","first-page":"562","DOI":"10.12659\/AJCR.892264","article-title":"Transient serotonin syndrome caused by concurrent use of tramadol and selective serotonin reuptake inhibitor","volume":"15","author":"Shakoor","year":"2014","journal-title":"Am. J. Case Rep."},{"issue":"6","key":"10.1016\/j.jmsacl.2025.04.008_b0170","doi-asserted-by":"crossref","first-page":"1257","DOI":"10.1089\/jpm.2006.9.1257","article-title":"A case of serotonin syndrome and mutism associated with methadone","volume":"9","author":"Bush","year":"2006","journal-title":"J. Palliat. Med.,"},{"key":"10.1016\/j.jmsacl.2025.04.008_b0175","doi-asserted-by":"crossref","unstructured":"N. Matsumura, Y. Nitta, T. Endo, T. Kobayashi, S. Yoshida. Serotonin syndrome induced by fentanyl alone in an adult patient after cardiac surgery: a case report. Cureus, 16 (7) (2024), e64832, https:\/\/doi.org\/10.7759\/cureus.64832. eCollection 2024 Jul.","DOI":"10.7759\/cureus.64832"},{"key":"10.1016\/j.jmsacl.2025.04.008_b0180","first-page":"81","article-title":"Serotonin syndrome with escitolapram and concomitant use of cocaine: a case report","volume":"5","author":"Ur-R","year":"2012","journal-title":"Clin. Med. Insights Case Rep.,"},{"issue":"3","key":"10.1016\/j.jmsacl.2025.04.008_b0185","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1515\/ijamh-2013-0052","article-title":"Ecstasy use and serotonin syndrome: a neglected danger to adolescents and young adults prescribed selective serotonin reuptake inhibitors","volume":"25","author":"Dobry","year":"2013","journal-title":"Int. J. Adolesc. Med. Health"},{"issue":"2","key":"10.1016\/j.jmsacl.2025.04.008_b0190","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1097\/WNF.0000000000000075","article-title":"Serotonin syndrome with sertraline and methylphenidate in an adolescent","volume":"38","author":"T\u00fcrko\u011flu","year":"2015","journal-title":"Clin. Neuropharmacol.,"},{"issue":"9","key":"10.1016\/j.jmsacl.2025.04.008_b0195","doi-asserted-by":"crossref","first-page":"1069.e1","DOI":"10.1016\/j.ajem.2008.03.028","article-title":"Serotonin syndrome in a patient taking Lexapro and Flexeril: a case report","volume":"26","author":"Day","year":"2008","journal-title":"Am. J. Emerg. Med.,"},{"issue":"12","key":"10.1016\/j.jmsacl.2025.04.008_b0200","doi-asserted-by":"crossref","first-page":"2069","DOI":"10.3390\/jpm12122069","article-title":"Recognition and management of serotonin toxidrome in the emergency department-case based review","volume":"12","author":"Morarasu","year":"2022","journal-title":"J. Pers. Med.,"},{"issue":"3","key":"10.1016\/j.jmsacl.2025.04.008_b0205","doi-asserted-by":"crossref","first-page":"388","DOI":"10.1345\/aph.1C228","article-title":"Combination risperidone and SSRI-induced serotonin syndrome","volume":"37","author":"Karki","year":"2003","journal-title":"Ann. Pharmacother.,"},{"issue":"3","key":"10.1016\/j.jmsacl.2025.04.008_b0210","doi-asserted-by":"crossref","first-page":"234","DOI":"10.1097\/PRA.0000000000000787","article-title":"Recurrent serotonin syndrome after ketamine-assisted electroconvulsive therapy: a case report and review of the literature","volume":"30","author":"Deka","year":"2024","journal-title":"Psychiatr. Pract.,"},{"issue":"6","key":"10.1016\/j.jmsacl.2025.04.008_b0215","doi-asserted-by":"crossref","first-page":"1396","DOI":"10.1177\/08971900241248871","article-title":"Take it easy! Serotonin syndrome precipitated by the rapid titration of sertraline and trazodone in the setting of risperidone use","volume":"37","author":"Martino","year":"2024","journal-title":"Pharm. Pract.,"},{"issue":"10","key":"10.1016\/j.jmsacl.2025.04.008_b0220","doi-asserted-by":"crossref","first-page":"1647","DOI":"10.1345\/aph.1C091","article-title":"Serotonin syndrome induced by amitriptyline, meperidine, and venlafaxine","volume":"36","author":"Dougherty","year":"2002","journal-title":"Ann. Pharmacother.,"},{"issue":"4","key":"10.1016\/j.jmsacl.2025.04.008_b0225","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1007\/s12245-010-0195-7","article-title":"The serotonin syndrome-the need for physician's awareness","volume":"3","author":"Arora","year":"2010","journal-title":"Int. J. Emerg. Med.,"},{"key":"10.1016\/j.jmsacl.2025.04.008_b0230","doi-asserted-by":"crossref","unstructured":"M. Monteiro, N.C. Pinheiro, V. Samji. Serotonin syndrome: an emerging reality in the emergency department, Cureus, 15 (10) (2023) e47470, https:\/\/doi.org\/10.7759\/cureus.47470. eCollection 2023 Oct.","DOI":"10.7759\/cureus.47470"},{"issue":"1","key":"10.1016\/j.jmsacl.2025.04.008_b0235","doi-asserted-by":"crossref","first-page":"1","DOI":"10.4103\/jfcm.jfcm_236_23","article-title":"Serotonin syndrome: an often-neglected medical emergency","volume":"31","author":"Badar","year":"2024","journal-title":"J. Family Community Med.,"},{"issue":"2023","key":"10.1016\/j.jmsacl.2025.04.008_b0240","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1016\/j.jmsacl.2023.02.007","article-title":"Bridging the gap: the critical role of laboratory developed tests in clinical toxicology","volume":"28","author":"Noguez","year":"2023","journal-title":"J. Mass Spectrom. Adv. Clin. Lab.,"}],"container-title":["Journal of Mass Spectrometry and Advances in the Clinical Lab"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2667145X2500015X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2667145X2500015X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,1,7]],"date-time":"2026-01-07T07:22:49Z","timestamp":1767770569000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2667145X2500015X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,8]]},"references-count":48,"alternative-id":["S2667145X2500015X"],"URL":"https:\/\/doi.org\/10.1016\/j.jmsacl.2025.04.008","relation":{},"ISSN":["2667-145X"],"issn-type":[{"value":"2667-145X","type":"print"}],"subject":[],"published":{"date-parts":[[2025,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Definitive urine drug testing in emergency medicine: Recreational and psychiatric drug findings","name":"articletitle","label":"Article Title"},{"value":"Journal of Mass Spectrometry and Advances in the Clinical Lab","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jmsacl.2025.04.008","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 THE AUTHORS. Publishing services by ELSEVIER B.V. on behalf of MSACL.","name":"copyright","label":"Copyright"}]}}